Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Statement regarding press speculation

29 Jan 2021 11:24

RNS Number : 3843N
Marston's PLC
29 January 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

Friday 29th January, 2021Marston's PLC

Statement regarding press speculation

The Board of Marston's PLC ("Marston's" or the "Company") notes the press speculation and confirms that it has today received an unsolicited non-binding proposal from Platinum Equity Advisors, LLC ("Platinum") regarding a possible cash offer for the entire issued, and to be issued, share capital of Marston's (the "Proposal").

The Board will evaluate the Proposal with its advisers and a further announcement will be made in due course. There can be no certainty that any firm offer will be made for the Company, nor as to the terms on which any firm offer might be made.

In accordance with Rule 2.6(a) of the Code, Platinum, is required, by no later than 5.00 p.m. (London time) on Friday 26th February 2021, being 28 days after today's date, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel (the "Panel") in accordance with Rule 2.6(c) of the Code.

Enquiries:

 

Marston's PLC

Tel: 01902 329516

Ralph Findlay, CEO

Andrew Andrea, CFO

J.P. Morgan Cazenove

Tel: 020 7742 4000

James Mitford / Anastasia Volnova

Dwayne Lysaght / Jonty Edwards

Instinctif Partners

Tel: 020 7457 2010/2005

Justine Warren

Matthew Smallwood

 

 

Disclaimer

J.P. Morgan Securities PLC, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Marston's and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Marston's for providing the protections afforded to clients of J.P. Morgan Cazenove, or for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.marstons.co.uk, by no later than 12 noon (London time) on 1st February 2021. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) of the Code applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8 of the Code. A Dealing Disclosure by a person to whom Rule 8.3(b) of the Code applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCUKUARAUUAUAR
Date   Source Headline
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.